Navigation Links
Fatigue in Biological Technology

You: Being Beautiful Authors Mehmet Oz, MD, & Michael Roizen, MD, Call Ribose One of the Decade's 'Real Nutritional Heroes'

... Medical Director of the national Fibromyalgia and fatigue Centers, Inc., and best-selling author of ... is being reflected not only in the high levels of fatigue but in the accompanying epidemic of pain ... overcome the debilitating effects of Chronic fatigue Syndrome and fibromyalgia as well as a general ...

Golimumab Phase 3 Data Show Significant Improvement In Physical Function In Patients with Rheumatoid Arthritis

... Improvements in Quality of Life Measures and fatigue Despite Treatment with Other Anti-TNFs or ... 13-item questionnaire that assesses self-reported fatigue and its impact on daily activities and function. ... with fatigue. "Patients with RA often say that fatigue is one of their most frustrating symptoms because ...

Job-related stress: NIST demonstrates fatigue effects in silicon

... Technology (NIST) have demonstrated a mechanical fatigue process that eventually leads to cracks and ... and it has long been believed to be immune to fatigue from cyclic stresses because of the nature of its ... The NIST experiments demonstrated fatigue effects in silicon at the comparatively large ...

Bioenergy Life Science and Integrative Therapeutics, Inc. Form Exclusive Co-Marketing Alliance

... with congestive heart failure (CHF), decrease fatigue caused by Chronic fatigue Syndrome (CFS) and fibromyalgia (FMS), and ... functioning for patients with Chronic fatigue Syndrome and fibromyalgia. "The research helped ...

Video: Varicose Veins, Much More Than a Cosmetic Issue, Can Prove a Health Risk

... bodies and speak with a doctor if they experience any pain, swelling, and fatigue in the legs as these can be symptoms of varicose veins." Varicose ... of faulty valves and weakened vein walls and can lead to pain swelling and fatigue in the legs. While surgical treatments have traditionally been used ...

Fitter frames: Nanotubes boost structural integrity of composites

... into an epoxy composite can significantly improve the overall toughness, fatigue resistance, and durability of a composite frame. When subjected to ... type of epoxy composite we used," Koratkar said. "In addition to improved fatigue resistance and toughness, the treated nanotubes also enhanced the ...

FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania

... appetite (12% vs. 6%), weight gain (7% vs. 1%), dyspepsia (7% vs. 1%), and fatigue (6% vs. 2%).(5) The bipolar mania submission was based on a clinical ... (7% vs. 5%), weight gain (7% vs. 1%), increased appetite (12% vs. 6%), fatigue (6-7% vs. 2-4%), dysarthria (5% vs. 0%), and nasal congestion (5% vs. ...

Lilly to Acquire ImClone Systems in $6.5 Billion Transaction

... + best supportive care arm (incidence greater than or equal to 50%) were fatigue (89%), rash/desquamation (89%), abdominal pain (59%), and pain-other ... common grade 3/4 adverse events (greater than or equal to 10%) included: fatigue (33%), pain-other (16%), dyspnea (16%), abdominal pain (14%), infection ...

Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After Surgery

... (all Grades) in the 12 DFSP patients assessed included nausea and fatigue (42% each); periorbital, peripheral and eye edema (33% each); diarrhea, ... 77%), nausea (63%; 74%), muscle cramps (47%; 58%), diarrhea (59%; 70%), fatigue (48%; 53%), abdominal pain (40%; 37%), rash and related terms (38%; 53%), ...

Kosan's Hsp90 Inhibitor, Tanespimycin, Shows 55% Clinical Benefit in Patients With Trastuzumab-Refractory Metastatic Breast Cancer

... disease. Common toxicities were mainly mild to moderate and included fatigue and gastrointestinal symptoms. Data from the Phase 2 trial were presented ... Grade 3 toxicities were experienced by 3 patients and included reversible fatigue and headache, increased liver function tests that resolved in 9 days and ...

U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) as the First Medication for Add-On Treatment of Major Depressive Disorder (MDD)

... insomnia (8 percent vs 2 percent), constipation (5 percent vs 2 percent), fatigue (8 percent vs 4 percent) and blurred vision (6 percent vs 1 percent). ... (8 percent vs 2 percent), constipation (5 percent vs 2 percent), fatigue (8 percent vs 4 percent), and blurred vision (6 percent vs 1 percent). ...

PROTOMED SA Chooses HyperWorks to Simulate Implantable Medical Devices

... device development and test services activities," said Frederic Mouret, CEO and founder of PROTOMED. "HyperWorks is an essential component of our fatigue simulation efforts, computational fluid mechanics and trauma simulation capabilities. It will reinforce our technical resources and our ability to ...

Schering-Plough Announces Phase II and III Data for Corifollitropin Alfa

... treatment with corifollitropin alfa in clinical trials are Ovarian Hyperstimulation Syndrome (OHSS), pelvic pain and discomfort, headache, nausea, fatigue and breast complaints (including tenderness). They are reported with an incidence between 1% and 6%. About Infertility Infertility is a ...

New Survey Reveals That More Than Half of Rheumatoid Arthritis Patients in Europe and Canada Feel Their Disease Controls Their Lives

... of more than 500 rheumatoid arthritis (RA) patients throughout Europe and Canada revealed a majority of patients still suffer from pain (79 percent), fatigue (67 percent) and joint stiffness (57 percent) on a regular basis despite current treatment, while more than half (51 percent) of RA patients feel ...

Cimzia(R) (certolizumab pegol) Provides Long-Term Remission and Response Rates in Infliximab-Refractory Crohn's Patients

... pyrexia (3% CIMZIA, 2% placebo), pharyngitis (3% CIMZIA, 1% placebo), rash (3% CIMZIA, 1% placebo), acute bronchitis (3% CIMZIA, 1% placebo), fatigue (3% CIMZIA, 1% placebo). Hypertensive adverse reactions were observed more frequently in patients receiving CIMZIA than in controls. These adverse ...

Ascenta Therapeutics Announces Presentation of Promising Results From Clinical Trials of AT-101 in Prostate, Brain, and Lung Cancers at 2009 ASCO Annual Meeting

... increase in median survival and a 34 percent increase in 6-month survival compared to the docetaxel plus placebo arm. Common adverse events included fatigue (18 percent), anemia (18 percent) and dyspnea (18 percent). Using NSCLC cell lines, a genomic profile predicting response to AT-101 was developed in ...

OncoGenex Pharmaceuticals Announces OGX-427 Treatment Demonstrates Safety, Evidence of Declines in Circulating Tumor Cells and Reductions in Tumor Markers in a Phase 1 Cancer Trial

... Majority of adverse events were mild and mainly occurred during the loading doses. Adverse events consisted of chills, itching and fatigue in over a third of patients. - There was a trend for increasing incidence of some mild adverse events with escalating OGX-427 doses. ...

Centocor Ortho Biotech Data to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting

... ARs >20% (VELCADE plus DOXIL vs VELCADE, respectively) included: neutropenia (36% vs 22%), thrombocytopenia (33% vs 28%), anemia (25% vs 21%), fatigue (36% vs 28%), pyrexia (31% vs 22%), asthenia (22% vs 18%), nausea (48% vs 40%), diarrhea (46% vs 39%), vomiting (32% vs 22%), constipation (31% vs ...

University of Illinois Medical Center in Chicago First Hospital to Install Innovative Shape-HF™ Cardiopulmonary Testing System

... monitoring their response to therapy and predicting outcome. Shape-HF™ is designed to quantify the severity of dyspnea on exertion and fatigue and evaluate the interaction between the heart, lungs, and other organ systems. This makes it possible for the physician to evaluate therapy options ...

Lumenis(R) Introduces Cost-Saving Innovations at the 2009 American Academy of Dermatology (AAD) Annual Meeting

... clinicians to treat large areas easily and quickly, leading to a significant reduction in treatment time, which essentially eliminates clinician fatigue and revolutionizes treatment economics. About UltraPulse 4X Lumenis C02 Laser Systems pioneered resurfacing more than 18 years ago and ...

Pro Hockey Player Fernando Pisani Looks to Shoot and Score Against Ulcerative Colitis

... Pisani first began experiencing the painful symptoms of UC prior to the start of the 2007-08 season. Pisani experienced significant weight loss, fatigue and found it extremely difficult to keep up with the demands of playing professional hockey. The disease eventually caused Fernando to be sidelined ...

Video: Experts Unite to Help People Manage Spring Nasal Allergy Sneezin'

... patients (12 years of age and older) taking XYZAL(R) 2.5 mg, XYZAL(R) 5 mg, or placebo were somnolence (5%, 6%, 2%), nasopharyngitis (6%, 4%, 3%), fatigue (1%, 4%, 2%), dry mouth (3%, 2%, 1%), and pharyngitis (2%, 1%, 1%), respectively. In clinical trials 4 to 6 weeks in duration, the most common ...

The Holtorf Medical Group and Yan Center for Corrective & Cosmetic Surgery Tap 5W Public Relations

... Francisco, Dr. Holtorf and his staff are experts in natural bioidentical hormone replacement and optimization for women and men, as well as chronic fatigue syndrome, fibromyalgia, adrenal insufficiency, thyroid dysfunction and complex endocrine dysfunction. www.HoltorfMed.com About The Yan Center ...

InterMune Reports Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF

... as compared to placebo in either study were nausea (35% vs. 18% in CAPACITY 2 and 38% vs. 16% in CAPACITY 1), rash (31% vs. 10% and 34% vs. 13%), fatigue (28% vs. 21% and 33% vs. 20%), diarrhea (25% vs. 17% and 33% vs. 21%), dyspepsia (17% vs. 9% and 21% vs. 6%), and dizziness (19% vs. 10% and 18% vs. ...

First United Kingdom Patients Treated With Percutaneous MitraClip(R) System

... does not require a heart-lung bypass machine. In addition to improving blood flow through the heart, the procedure may also relieve symptoms such as fatigue and shortness of breath that often affect patients with significant MR. After treatment, patients generally recover quickly. The MitraClip(R) device ...

Bioenergy D-Ribose Achieves Highest Safety Standard

... as a Medical Food, D-Ribose also has been shown to assist patients with compromised heart function and is also widely used by patients with Chronic fatigue Syndrome (CFS) and Fibromyalgia (FMS). Bioenergy, Inc. ( http://www.bioenergy.com ) is a privately held, Minneapolis-based life sciences ...

Huifeng Bio-Pharmaceutical (HFGB) Announces USD $1.1 Million Supply Agreement with DNP International Co. Inc.

... is in many energy drinks. Because most of these drinks also contain caffeine, Glucuronolactone is included because it is purported to fight fatigue and provide a sense of well-being. According to "The Merck Index" (14th edition) it is also used as detoxicant. (From Wikipedia) About DNP ...

Raj Khankari Named Bioenergy, Inc., CEO

... by improving diastolic heart function, ventilation, exercise capacity, and oxygen uptake efficiency. It's also widely used to help treat Chronic fatigue Syndrome (CFS) and Fibromyalgia (FMS). D-ribose is commonly found in more and more functional foods like energy bars (e.g., Detour, FastFuel, ...

Video: Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia

... Adverse reactions In chronic phase patients, the most commonly reported adverse reactions ( > 10%) were rash (33%), pruritus (29%), nausea (31%), fatigue (28%), headache (31%), constipation (21%), diarrhea (22%), and vomiting (21%). The most common ( > 10%) Grade 3/4 adverse reactions were ...

MultiCell Technologies Relocates Corporate Headquarters

... MultiCell Technologies, Inc. is a biopharmaceutical company developing new therapeutics including: MCT-125 for the treatment of primary fatigue in MS patients. MCT-175 for the treatment of relapsing-remitting MS. MCT-465 for the treatment of TLR3 positive breast cancers. MCT-475 for the ...

SURGEX(TM) Becomes the Official Sports Nutrition Drink of Former NBA Player Dee Brown and his Edge Basketball Training Facility

... of exercise. SURGEX(TM) proved to be a superior product by improving peak power outputs, lowering oxidative stress/inflammatory markers, reducing fatigue (poor energy recovery) and the breakdown of muscle (post exercise wasting), as well as reducing free radical production (oxidative stress). The ...

D-Ribose Helps Energy-Starved Hearts

... the age of nine. Nothing a good night's sleep couldn't fix. Then came a sixth son, and she began experiencing palpitations, breathlessness and fatigue whenever she played with the kids or went for a walk with her husband. And even after eight hours of sleep, she couldn't shake the exhaustion. During ...

Medarex Reports Phase 1/2 Clinical Data of MDX-060 in Lymphoma at American Association for Cancer Research Meeting

... MDX-060 treatment was well-tolerated with no clinically meaningful infusion reactions. The most frequently reported drug-related adverse events were fatigue and pyrexia considered to be mild to moderate in severity. About Anti-CD30 Antibody Therapy MDX-060 is a fully human antibody that targets CD30, ...

FDA Approves PRISTIQ(TM) for the Treatment of Adult Patients with Major Depressive Disorder

... depressed mood; loss of interest or pleasure; changes in appetite or weight; changes in sleeping patterns; psychomotor agitation or retardation; fatigue or low energy; feeling worthless or guilty for no reason; difficulty thinking or concentrating; or thoughts of death or suicide. Further, people with ...

LPGA Pro, Jill McGill, Encourages Indoor and Outdoor Allergy Sufferers to Challenge Their Course

... patients (12 years of age and older) taking XYZAL(R) 2.5 mg, XYZAL(R) 5 mg, or placebo were somnolence (5%, 6%, 2%), nasopharyngitis (6%, 4%, 3%), fatigue (1%, 4%, 2%), dry mouth (3%, 2%, 1%), and pharyngitis (2%, 1%, 1%), respectively. In clinical trials, the most common adverse reactions in greater ...

Tom Shaw's NFL Training Center Chooses SURGEX(TM) as Their Exclusive Post Training Nutritional Regimen

... by assisting in reducing the damaging effects of exercise by improving peak power outputs, lowering oxidative stress/inflammatory markers, reducing fatigue (poor energy recovery) and the breakdown of muscle (post exercise wasting), as well as the lessening of free radical production (oxidative stress). ...

Pro Football Prospects Training at TEST Sports Clubs(TM) Use SURGEX(TM) as Part of Their Pre-Combine Training Regime

... by assisting in reducing the damaging effects of exercise by improving peak power outputs, lowering oxidative stress/inflammatory markers, reducing fatigue (poor energy recovery) and the breakdown of muscle (post exercise wasting), as well as the lessening of free radical production (oxidative stress). ...

MultiCell Technologies To Increase Focus on Therapeutic Candidates

... MultiCell Technologies, Inc. is a biopharmaceutical company developing new therapeutics including: MCT-125 for the treatment of primary fatigue in MS patients. MCT-175 for the treatment of relapsing-remitting MS. MCT-465 for the treatment of TLR3 positive breast cancers. MCT-475 for the ...

Bystolic(TM), a Novel Beta Blocker, is Now Approved by the FDA for the Treatment of Hypertension

... not receive beta blockers. Bystolic should not be combined with other beta blockers. The most common adverse events with Bystolic were headache, fatigue and dizziness. About Forest Laboratories and Its Products Forest Laboratories (http://www.frx.com ) is a US-based pharmaceutical ...

GlaxoSmithKline Announces Data on TYKERB(R) (Lapatinib) Plus Capecitabine for the Treatment of HER2 Positive Breast Cancer Brain Metastases

... The most common Grade 3 adverse events include hand-foot syndrome (8 percent), nausea (8 percent), vomiting (6 percent), diarrhea (4 percent) and fatigue (2 percent). "This trial and the ongoing clinical development program for TYKERB represent GSK Oncology's commitment to developing treatments that ...
Other Contents
(Date:7/31/2014)... , July 31, 2014 Biometrics ... and innovative smart technologies; companies turn towards digital currency: ... EBAY ), Amazon.com Inc. (NASDAQ: AMZN ), ... (NASDAQ: GOOG ) and Microsoft Corporation (NASDAQ: ... focused on the growing m-commerce market, announces a video ...
(Date:7/31/2014)... NXT-ID, Inc., (NXTD: OTCQB) a biometric authentication company ... and consumers wanting to learn more about its  ... on-air today, July 31 st . ... featured in a segment of NewsWatch, a weekly ... the History Channel, FYI Network today. ...
(Date:7/31/2014)... noise can affect animal movement and communication, with unknown ... Exeter and the cole Pratique des Hautes tudes (EPHE) ... embryonic development and increases larval mortality in sea hares. ... striatus used in this study) usually hatch from ... toxic alga but this study, conducted in a coral ...
Breaking Biology News(10 mins):Smart Technology Consumer's Interest in Mobile Payment Products Grows - Company Secures Deal with Major Airline to Display Advertisements in Flight for its Next Generation Smart Wallet 2Smart Technology Consumer's Interest in Mobile Payment Products Grows - Company Secures Deal with Major Airline to Display Advertisements in Flight for its Next Generation Smart Wallet 3Smart Technology Consumer's Interest in Mobile Payment Products Grows - Company Secures Deal with Major Airline to Display Advertisements in Flight for its Next Generation Smart Wallet 4Smart Technology Consumer's Interest in Mobile Payment Products Grows - Company Secures Deal with Major Airline to Display Advertisements in Flight for its Next Generation Smart Wallet 5Smart Technology Consumer's Interest in Mobile Payment Products Grows - Company Secures Deal with Major Airline to Display Advertisements in Flight for its Next Generation Smart Wallet 6NXT-ID's Next Generation Biometric Smart Wallet Featured on NewsWatch Consumer Show on the History Channel and FYI Network Today, July 31st 2NXT-ID's Next Generation Biometric Smart Wallet Featured on NewsWatch Consumer Show on the History Channel and FYI Network Today, July 31st 3Boat noise impacts development and survival of sea hares 2
(Date:7/31/2014)... Agebc.com, a popular online shop of wedding dresses and women’s ... mother of the bride dresses . Aside from that, ... to 68% off. , “We are proud to enrich ... of the bride dresses. We launch the special offer to ... shop has received thousands of rave reviews from new and ...
(Date:7/31/2014)... ReputationChief.Com, a well-recognized online reputation ... management service named ‘Remove Pissed Consumer’. The service ... rid of Pissed Consumer Complaints. , Remove Pissed ... ReputationChief.Com management assigned the responsibility to vet professionals ... struggling in their social or professional life on ...
(Date:7/31/2014)... The neurovascular interventions market in the ... slowly throughout the forecast period. The neurovascular ... rising prevalence of cerebrovascular disease; the cost ... Medicare, and private health insurance companies; and ... flow diverters and stent retrievers. , Complete ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 Ethane ... Company, has introduced a new service named ‘Java ... Ethane Web Technologies has designed the service after ... clients and Java Development service being provided by ... company a confidence to promise outstanding Java Development ...
(Date:7/31/2014)... A new catheter being used ... patients who have an abnormal heart rhythm. , ... procedures for patients such as those suffering from ... Heart Specialists were the first in north Florida ... spring, according to Biosense Webster, which develops the ...
Breaking Medicine News(10 mins):Health News:Mother of the Bride Dresses Now Available With Great Discounts at Agebc.com 2Health News:ReputationChief.Com Announces a New Online Reputation Management Service 2Health News:US Neurovascular Interventions Market Worth $702m by 2020 Says a New Report Available at MarketOptimizer.org 2Health News:US Neurovascular Interventions Market Worth $702m by 2020 Says a New Report Available at MarketOptimizer.org 3Health News:US Neurovascular Interventions Market Worth $702m by 2020 Says a New Report Available at MarketOptimizer.org 4Health News:US Neurovascular Interventions Market Worth $702m by 2020 Says a New Report Available at MarketOptimizer.org 5Health News:Ethane Web Technologies Announces Java Development Service at Pocket Friendly Cost 2Health News:New Catheter Improves Outcomes for Abnormal Heart Beat 2Health News:New Catheter Improves Outcomes for Abnormal Heart Beat 3
Other TagsOther Tags